nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Mometasone—systemic scleroderma	0.233	0.468	CbGbCtD
Fenofibrate—CYP2C9—Leflunomide—systemic scleroderma	0.105	0.21	CbGbCtD
Fenofibrate—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0928	0.186	CbGbCtD
Fenofibrate—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0376	0.0755	CbGbCtD
Fenofibrate—CYP3A4—Prednisone—systemic scleroderma	0.0301	0.0604	CbGbCtD
Fenofibrate—CYP2C9—cardial valve—systemic scleroderma	0.0279	0.452	CbGeAlD
Fenofibrate—PPARA—blood vessel—systemic scleroderma	0.0101	0.164	CbGeAlD
Fenofibrate—PPARA—connective tissue—systemic scleroderma	0.00519	0.0842	CbGeAlD
Fenofibrate—PPARA—smooth muscle tissue—systemic scleroderma	0.00475	0.077	CbGeAlD
Fenofibrate—PPARA—skin of body—systemic scleroderma	0.00469	0.076	CbGeAlD
Fenofibrate—PPARA—digestive system—systemic scleroderma	0.00375	0.0608	CbGeAlD
Fenofibrate—PPARA—lung—systemic scleroderma	0.00313	0.0508	CbGeAlD
Fenofibrate—CYP2C9—digestive system—systemic scleroderma	0.00121	0.0196	CbGeAlD
Fenofibrate—CYP3A4—digestive system—systemic scleroderma	0.00092	0.0149	CbGeAlD
Fenofibrate—Abdominal pain—Azathioprine—systemic scleroderma	0.000248	0.000565	CcSEcCtD
Fenofibrate—Body temperature increased—Azathioprine—systemic scleroderma	0.000248	0.000565	CcSEcCtD
Fenofibrate—Skin disorder—Lisinopril—systemic scleroderma	0.000248	0.000563	CcSEcCtD
Fenofibrate—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000561	CcSEcCtD
Fenofibrate—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000247	0.00056	CcSEcCtD
Fenofibrate—Diarrhoea—Captopril—systemic scleroderma	0.000246	0.00056	CcSEcCtD
Fenofibrate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000246	0.000559	CcSEcCtD
Fenofibrate—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000559	CcSEcCtD
Fenofibrate—Erectile dysfunction—Prednisone—systemic scleroderma	0.000245	0.000557	CcSEcCtD
Fenofibrate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000557	CcSEcCtD
Fenofibrate—Feeling abnormal—Leflunomide—systemic scleroderma	0.000245	0.000556	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000244	0.000555	CcSEcCtD
Fenofibrate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000244	0.000555	CcSEcCtD
Fenofibrate—Nausea—Mometasone—systemic scleroderma	0.000244	0.000553	CcSEcCtD
Fenofibrate—Anorexia—Lisinopril—systemic scleroderma	0.000243	0.000552	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000243	0.000551	CcSEcCtD
Fenofibrate—Weight increased—Prednisone—systemic scleroderma	0.000242	0.000551	CcSEcCtD
Fenofibrate—Pain—Mycophenolic acid—systemic scleroderma	0.000242	0.00055	CcSEcCtD
Fenofibrate—Constipation—Mycophenolic acid—systemic scleroderma	0.000242	0.00055	CcSEcCtD
Fenofibrate—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000242	0.00055	CcSEcCtD
Fenofibrate—Weight decreased—Prednisone—systemic scleroderma	0.000241	0.000548	CcSEcCtD
Fenofibrate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000543	CcSEcCtD
Fenofibrate—Hypotension—Lisinopril—systemic scleroderma	0.000238	0.000541	CcSEcCtD
Fenofibrate—Dizziness—Captopril—systemic scleroderma	0.000238	0.000541	CcSEcCtD
Fenofibrate—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000238	0.00054	CcSEcCtD
Fenofibrate—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000537	CcSEcCtD
Fenofibrate—Urticaria—Leflunomide—systemic scleroderma	0.000236	0.000536	CcSEcCtD
Fenofibrate—Abdominal pain—Leflunomide—systemic scleroderma	0.000235	0.000533	CcSEcCtD
Fenofibrate—Body temperature increased—Leflunomide—systemic scleroderma	0.000235	0.000533	CcSEcCtD
Fenofibrate—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000234	0.000532	CcSEcCtD
Fenofibrate—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000233	0.00053	CcSEcCtD
Fenofibrate—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00053	CcSEcCtD
Fenofibrate—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00053	CcSEcCtD
Fenofibrate—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000233	0.00053	CcSEcCtD
Fenofibrate—Myocardial infarction—Prednisone—systemic scleroderma	0.000233	0.000529	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000232	0.000528	CcSEcCtD
Fenofibrate—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000528	CcSEcCtD
Fenofibrate—Hypersensitivity—Azathioprine—systemic scleroderma	0.000232	0.000526	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000232	0.000526	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000231	0.000526	CcSEcCtD
Fenofibrate—Insomnia—Lisinopril—systemic scleroderma	0.000231	0.000524	CcSEcCtD
Fenofibrate—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000523	CcSEcCtD
Fenofibrate—Paraesthesia—Lisinopril—systemic scleroderma	0.000229	0.00052	CcSEcCtD
Fenofibrate—Vomiting—Captopril—systemic scleroderma	0.000229	0.00052	CcSEcCtD
Fenofibrate—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000518	CcSEcCtD
Fenofibrate—Dyspnoea—Lisinopril—systemic scleroderma	0.000227	0.000517	CcSEcCtD
Fenofibrate—Rash—Captopril—systemic scleroderma	0.000227	0.000516	CcSEcCtD
Fenofibrate—Dermatitis—Captopril—systemic scleroderma	0.000227	0.000515	CcSEcCtD
Fenofibrate—Somnolence—Lisinopril—systemic scleroderma	0.000227	0.000515	CcSEcCtD
Fenofibrate—Headache—Captopril—systemic scleroderma	0.000226	0.000513	CcSEcCtD
Fenofibrate—Dyspepsia—Lisinopril—systemic scleroderma	0.000224	0.00051	CcSEcCtD
Fenofibrate—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000224	0.000509	CcSEcCtD
Fenofibrate—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000224	0.000509	CcSEcCtD
Fenofibrate—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000508	CcSEcCtD
Fenofibrate—Asthma—Methotrexate—systemic scleroderma	0.000223	0.000506	CcSEcCtD
Fenofibrate—Infection—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000504	CcSEcCtD
Fenofibrate—Decreased appetite—Lisinopril—systemic scleroderma	0.000222	0.000504	CcSEcCtD
Fenofibrate—Eosinophilia—Methotrexate—systemic scleroderma	0.00022	0.000501	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00022	0.0005	CcSEcCtD
Fenofibrate—Fatigue—Lisinopril—systemic scleroderma	0.00022	0.0005	CcSEcCtD
Fenofibrate—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000498	CcSEcCtD
Fenofibrate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000497	CcSEcCtD
Fenofibrate—Hypersensitivity—Leflunomide—systemic scleroderma	0.000219	0.000497	CcSEcCtD
Fenofibrate—Pancreatitis—Methotrexate—systemic scleroderma	0.000218	0.000496	CcSEcCtD
Fenofibrate—Pain—Lisinopril—systemic scleroderma	0.000218	0.000496	CcSEcCtD
Fenofibrate—Constipation—Lisinopril—systemic scleroderma	0.000218	0.000496	CcSEcCtD
Fenofibrate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000218	0.000496	CcSEcCtD
Fenofibrate—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000493	CcSEcCtD
Fenofibrate—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000491	CcSEcCtD
Fenofibrate—Diarrhoea—Azathioprine—systemic scleroderma	0.000215	0.000489	CcSEcCtD
Fenofibrate—Nausea—Captopril—systemic scleroderma	0.000214	0.000486	CcSEcCtD
Fenofibrate—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000484	CcSEcCtD
Fenofibrate—Asthenia—Leflunomide—systemic scleroderma	0.000213	0.000484	CcSEcCtD
Fenofibrate—Feeling abnormal—Lisinopril—systemic scleroderma	0.00021	0.000478	CcSEcCtD
Fenofibrate—Pruritus—Leflunomide—systemic scleroderma	0.00021	0.000477	CcSEcCtD
Fenofibrate—Connective tissue disorder—Prednisone—systemic scleroderma	0.000209	0.000476	CcSEcCtD
Fenofibrate—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000474	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000209	0.000474	CcSEcCtD
Fenofibrate—Dysuria—Methotrexate—systemic scleroderma	0.000208	0.000473	CcSEcCtD
Fenofibrate—Dizziness—Azathioprine—systemic scleroderma	0.000208	0.000472	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000207	0.00047	CcSEcCtD
Fenofibrate—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000205	0.000466	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000463	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000203	0.000462	CcSEcCtD
Fenofibrate—Asthenia—Mycophenolic acid—systemic scleroderma	0.000203	0.000462	CcSEcCtD
Fenofibrate—Diarrhoea—Leflunomide—systemic scleroderma	0.000203	0.000461	CcSEcCtD
Fenofibrate—Urticaria—Lisinopril—systemic scleroderma	0.000203	0.00046	CcSEcCtD
Fenofibrate—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000459	CcSEcCtD
Fenofibrate—Abdominal pain—Lisinopril—systemic scleroderma	0.000202	0.000458	CcSEcCtD
Fenofibrate—Body temperature increased—Lisinopril—systemic scleroderma	0.000202	0.000458	CcSEcCtD
Fenofibrate—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000456	CcSEcCtD
Fenofibrate—Pruritus—Mycophenolic acid—systemic scleroderma	0.0002	0.000455	CcSEcCtD
Fenofibrate—Vomiting—Azathioprine—systemic scleroderma	0.0002	0.000454	CcSEcCtD
Fenofibrate—Pneumonia—Methotrexate—systemic scleroderma	0.0002	0.000454	CcSEcCtD
Fenofibrate—Eye disorder—Prednisone—systemic scleroderma	0.000199	0.000453	CcSEcCtD
Fenofibrate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000453	CcSEcCtD
Fenofibrate—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000451	CcSEcCtD
Fenofibrate—Infestation NOS—Methotrexate—systemic scleroderma	0.000198	0.000451	CcSEcCtD
Fenofibrate—Infestation—Methotrexate—systemic scleroderma	0.000198	0.000451	CcSEcCtD
Fenofibrate—Rash—Azathioprine—systemic scleroderma	0.000198	0.00045	CcSEcCtD
Fenofibrate—Dermatitis—Azathioprine—systemic scleroderma	0.000198	0.00045	CcSEcCtD
Fenofibrate—Headache—Azathioprine—systemic scleroderma	0.000197	0.000447	CcSEcCtD
Fenofibrate—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000447	CcSEcCtD
Fenofibrate—Dizziness—Leflunomide—systemic scleroderma	0.000196	0.000446	CcSEcCtD
Fenofibrate—Renal failure—Methotrexate—systemic scleroderma	0.000195	0.000443	CcSEcCtD
Fenofibrate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000441	CcSEcCtD
Fenofibrate—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000194	0.00044	CcSEcCtD
Fenofibrate—Angiopathy—Prednisone—systemic scleroderma	0.000193	0.00044	CcSEcCtD
Fenofibrate—Conjunctivitis—Methotrexate—systemic scleroderma	0.000193	0.000438	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000438	CcSEcCtD
Fenofibrate—Pain—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000434	CcSEcCtD
Fenofibrate—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000434	CcSEcCtD
Fenofibrate—Arrhythmia—Prednisone—systemic scleroderma	0.00019	0.000433	CcSEcCtD
Fenofibrate—Sweating—Methotrexate—systemic scleroderma	0.00019	0.000432	CcSEcCtD
Fenofibrate—Vomiting—Leflunomide—systemic scleroderma	0.000189	0.000429	CcSEcCtD
Fenofibrate—Alopecia—Prednisone—systemic scleroderma	0.000188	0.000428	CcSEcCtD
Fenofibrate—Hypersensitivity—Lisinopril—systemic scleroderma	0.000188	0.000427	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000188	0.000427	CcSEcCtD
Fenofibrate—Dizziness—Mycophenolic acid—systemic scleroderma	0.000187	0.000425	CcSEcCtD
Fenofibrate—Rash—Leflunomide—systemic scleroderma	0.000187	0.000425	CcSEcCtD
Fenofibrate—Dermatitis—Leflunomide—systemic scleroderma	0.000187	0.000425	CcSEcCtD
Fenofibrate—Mental disorder—Prednisone—systemic scleroderma	0.000187	0.000424	CcSEcCtD
Fenofibrate—Nausea—Azathioprine—systemic scleroderma	0.000187	0.000424	CcSEcCtD
Fenofibrate—Headache—Leflunomide—systemic scleroderma	0.000186	0.000422	CcSEcCtD
Fenofibrate—Erythema—Prednisone—systemic scleroderma	0.000186	0.000422	CcSEcCtD
Fenofibrate—Malnutrition—Prednisone—systemic scleroderma	0.000186	0.000422	CcSEcCtD
Fenofibrate—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000418	CcSEcCtD
Fenofibrate—Asthenia—Lisinopril—systemic scleroderma	0.000183	0.000416	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000183	0.000415	CcSEcCtD
Fenofibrate—Pruritus—Lisinopril—systemic scleroderma	0.00018	0.00041	CcSEcCtD
Fenofibrate—Vomiting—Mycophenolic acid—systemic scleroderma	0.00018	0.000409	CcSEcCtD
Fenofibrate—Rash—Mycophenolic acid—systemic scleroderma	0.000179	0.000406	CcSEcCtD
Fenofibrate—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000178	0.000405	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—systemic scleroderma	0.000178	0.000405	CcSEcCtD
Fenofibrate—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000403	CcSEcCtD
Fenofibrate—Headache—Mycophenolic acid—systemic scleroderma	0.000177	0.000403	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—systemic scleroderma	0.000177	0.000402	CcSEcCtD
Fenofibrate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000401	CcSEcCtD
Fenofibrate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000401	CcSEcCtD
Fenofibrate—Nausea—Leflunomide—systemic scleroderma	0.000176	0.000401	CcSEcCtD
Fenofibrate—Diarrhoea—Lisinopril—systemic scleroderma	0.000174	0.000396	CcSEcCtD
Fenofibrate—Ill-defined disorder—Prednisone—systemic scleroderma	0.000172	0.000391	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—systemic scleroderma	0.000172	0.00039	CcSEcCtD
Fenofibrate—Anaemia—Prednisone—systemic scleroderma	0.000172	0.00039	CcSEcCtD
Fenofibrate—Dizziness—Lisinopril—systemic scleroderma	0.000169	0.000383	CcSEcCtD
Fenofibrate—Nausea—Mycophenolic acid—systemic scleroderma	0.000168	0.000382	CcSEcCtD
Fenofibrate—Malaise—Prednisone—systemic scleroderma	0.000167	0.00038	CcSEcCtD
Fenofibrate—Vertigo—Prednisone—systemic scleroderma	0.000167	0.000379	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—systemic scleroderma	0.000166	0.000378	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—systemic scleroderma	0.000165	0.000376	CcSEcCtD
Fenofibrate—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000374	CcSEcCtD
Fenofibrate—Vomiting—Lisinopril—systemic scleroderma	0.000162	0.000368	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—systemic scleroderma	0.000162	0.000367	CcSEcCtD
Fenofibrate—Rash—Lisinopril—systemic scleroderma	0.000161	0.000365	CcSEcCtD
Fenofibrate—Dermatitis—Lisinopril—systemic scleroderma	0.000161	0.000365	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000161	0.000365	CcSEcCtD
Fenofibrate—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000364	CcSEcCtD
Fenofibrate—Hypertension—Prednisone—systemic scleroderma	0.00016	0.000364	CcSEcCtD
Fenofibrate—Headache—Lisinopril—systemic scleroderma	0.00016	0.000363	CcSEcCtD
Fenofibrate—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000359	CcSEcCtD
Fenofibrate—Arthralgia—Prednisone—systemic scleroderma	0.000158	0.000359	CcSEcCtD
Fenofibrate—Myalgia—Prednisone—systemic scleroderma	0.000158	0.000359	CcSEcCtD
Fenofibrate—Anxiety—Prednisone—systemic scleroderma	0.000157	0.000358	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—systemic scleroderma	0.000157	0.000358	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000157	0.000357	CcSEcCtD
Fenofibrate—Discomfort—Prednisone—systemic scleroderma	0.000156	0.000355	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—systemic scleroderma	0.000156	0.000355	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—systemic scleroderma	0.000155	0.000352	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—systemic scleroderma	0.000155	0.000352	CcSEcCtD
Fenofibrate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000347	CcSEcCtD
Fenofibrate—Nausea—Lisinopril—systemic scleroderma	0.000151	0.000344	CcSEcCtD
Fenofibrate—Oedema—Prednisone—systemic scleroderma	0.000151	0.000344	CcSEcCtD
Fenofibrate—Infection—Prednisone—systemic scleroderma	0.00015	0.000342	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—systemic scleroderma	0.00015	0.000341	CcSEcCtD
Fenofibrate—Nervous system disorder—Prednisone—systemic scleroderma	0.000149	0.000338	CcSEcCtD
Fenofibrate—Tachycardia—Prednisone—systemic scleroderma	0.000148	0.000336	CcSEcCtD
Fenofibrate—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000336	CcSEcCtD
Fenofibrate—Skin disorder—Prednisone—systemic scleroderma	0.000147	0.000334	CcSEcCtD
Fenofibrate—Hyperhidrosis—Prednisone—systemic scleroderma	0.000146	0.000333	CcSEcCtD
Fenofibrate—Anorexia—Prednisone—systemic scleroderma	0.000144	0.000328	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000144	0.000327	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—systemic scleroderma	0.000143	0.000326	CcSEcCtD
Fenofibrate—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000323	CcSEcCtD
Fenofibrate—Rash—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00032	CcSEcCtD
Fenofibrate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00032	CcSEcCtD
Fenofibrate—Headache—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000318	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—systemic scleroderma	0.00014	0.000318	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—systemic scleroderma	0.000139	0.000317	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—systemic scleroderma	0.000139	0.000315	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000138	0.000314	CcSEcCtD
Fenofibrate—Insomnia—Prednisone—systemic scleroderma	0.000137	0.000311	CcSEcCtD
Fenofibrate—Paraesthesia—Prednisone—systemic scleroderma	0.000136	0.000309	CcSEcCtD
Fenofibrate—Cough—Methotrexate—systemic scleroderma	0.000135	0.000308	CcSEcCtD
Fenofibrate—Dyspepsia—Prednisone—systemic scleroderma	0.000133	0.000303	CcSEcCtD
Fenofibrate—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000302	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—systemic scleroderma	0.000132	0.0003	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—systemic scleroderma	0.000132	0.0003	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—systemic scleroderma	0.000132	0.0003	CcSEcCtD
Fenofibrate—Decreased appetite—Prednisone—systemic scleroderma	0.000132	0.000299	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000131	0.000298	CcSEcCtD
Fenofibrate—Fatigue—Prednisone—systemic scleroderma	0.000131	0.000297	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—systemic scleroderma	0.00013	0.000296	CcSEcCtD
Fenofibrate—Constipation—Prednisone—systemic scleroderma	0.00013	0.000294	CcSEcCtD
Fenofibrate—Infection—Methotrexate—systemic scleroderma	0.000126	0.000286	CcSEcCtD
Fenofibrate—Feeling abnormal—Prednisone—systemic scleroderma	0.000125	0.000284	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—systemic scleroderma	0.000124	0.000282	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000124	0.000282	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000124	0.000281	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—systemic scleroderma	0.000123	0.000279	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000122	0.000278	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—systemic scleroderma	0.000121	0.000274	CcSEcCtD
Fenofibrate—Urticaria—Prednisone—systemic scleroderma	0.00012	0.000273	CcSEcCtD
Fenofibrate—Abdominal pain—Prednisone—systemic scleroderma	0.00012	0.000272	CcSEcCtD
Fenofibrate—Body temperature increased—Prednisone—systemic scleroderma	0.00012	0.000272	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—systemic scleroderma	0.000118	0.000269	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000115	0.000262	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—systemic scleroderma	0.000114	0.00026	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—systemic scleroderma	0.000114	0.000258	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—systemic scleroderma	0.000113	0.000256	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—systemic scleroderma	0.000113	0.000256	CcSEcCtD
Fenofibrate—Hypersensitivity—Prednisone—systemic scleroderma	0.000112	0.000254	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—systemic scleroderma	0.000111	0.000253	CcSEcCtD
Fenofibrate—Decreased appetite—Methotrexate—systemic scleroderma	0.00011	0.00025	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000109	0.000248	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—systemic scleroderma	0.000109	0.000248	CcSEcCtD
Fenofibrate—Asthenia—Prednisone—systemic scleroderma	0.000109	0.000247	CcSEcCtD
Fenofibrate—Pain—Methotrexate—systemic scleroderma	0.000108	0.000246	CcSEcCtD
Fenofibrate—Pruritus—Prednisone—systemic scleroderma	0.000107	0.000243	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—systemic scleroderma	0.000104	0.000237	CcSEcCtD
Fenofibrate—Diarrhoea—Prednisone—systemic scleroderma	0.000104	0.000235	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000104	0.000235	CcSEcCtD
Fenofibrate—Urticaria—Methotrexate—systemic scleroderma	0.000101	0.000228	CcSEcCtD
Fenofibrate—Dizziness—Prednisone—systemic scleroderma	0.0001	0.000228	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—systemic scleroderma	0.0001	0.000227	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—systemic scleroderma	0.0001	0.000227	CcSEcCtD
Fenofibrate—Vomiting—Prednisone—systemic scleroderma	9.63e-05	0.000219	CcSEcCtD
Fenofibrate—Rash—Prednisone—systemic scleroderma	9.55e-05	0.000217	CcSEcCtD
Fenofibrate—Dermatitis—Prednisone—systemic scleroderma	9.54e-05	0.000217	CcSEcCtD
Fenofibrate—Headache—Prednisone—systemic scleroderma	9.49e-05	0.000216	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—systemic scleroderma	9.33e-05	0.000212	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—systemic scleroderma	9.08e-05	0.000206	CcSEcCtD
Fenofibrate—Nausea—Prednisone—systemic scleroderma	9e-05	0.000204	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—systemic scleroderma	8.95e-05	0.000203	CcSEcCtD
Fenofibrate—Diarrhoea—Methotrexate—systemic scleroderma	8.66e-05	0.000197	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—systemic scleroderma	8.37e-05	0.00019	CcSEcCtD
Fenofibrate—Vomiting—Methotrexate—systemic scleroderma	8.05e-05	0.000183	CcSEcCtD
Fenofibrate—Rash—Methotrexate—systemic scleroderma	7.98e-05	0.000181	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—systemic scleroderma	7.97e-05	0.000181	CcSEcCtD
Fenofibrate—Headache—Methotrexate—systemic scleroderma	7.93e-05	0.00018	CcSEcCtD
Fenofibrate—Nausea—Methotrexate—systemic scleroderma	7.52e-05	0.000171	CcSEcCtD
